E
MEDIROM Healthcare Technologies Inc.
MRM
$0.6526
-$0.0174-2.60%
E
Sell
11/14/2024Downgrade
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 11/14/2024 due to a major decline in the efficiency index, solvency index and total return index. Total capital declined 5.97% from $21.18M to $19.92M.
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 11/14/2024 due to a major decline in the efficiency index, solvency index and total return index. Total capital declined 5.97% from $21.18M to $19.92M.
D
Sell
6/21/2024Upgraded
MEDIROM Healthcare Technologies Inc. (MRM) was upgraded to D from E+ on 6/21/2024 due to a major increase in the efficiency index, solvency index and volatility index. Debt to equity declined from 11.35 to 10.48, and total capital increased 5.96% from $25.88M to $27.42M.
MEDIROM Healthcare Technologies Inc. (MRM) was upgraded to D from E+ on 6/21/2024 due to a major increase in the efficiency index, solvency index and volatility index. Debt to equity declined from 11.35 to 10.48, and total capital increased 5.96% from $25.88M to $27.42M.
E
Sell
1/4/2024Downgrade
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 1/4/2024 due to a significant decline in the efficiency index, valuation index and volatility index. Total capital declined 8.06% from $21.48M to $19.75M.
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 1/4/2024 due to a significant decline in the efficiency index, valuation index and volatility index. Total capital declined 8.06% from $21.48M to $19.75M.
D
Sell
6/13/2023Upgraded
MEDIROM Inc. (MRM) was upgraded to D from E+ on 6/13/2023 due to a significant increase in the efficiency index, valuation index and solvency index. Total capital increased 9.72% from $21.92M to $24.05M.
MEDIROM Inc. (MRM) was upgraded to D from E+ on 6/13/2023 due to a significant increase in the efficiency index, valuation index and solvency index. Total capital increased 9.72% from $21.92M to $24.05M.
E
Sell
3/14/2023Downgrade
MEDIROM Inc. (MRM) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
MEDIROM Inc. (MRM) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
MEDIROM Inc. (MRM) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
MEDIROM Inc. (MRM) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
MEDIROM Inc. (MRM) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and valuation index.
MEDIROM Inc. (MRM) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and valuation index.
D
Sell
12/28/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from D- on 12/28/2022 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 10.33% from -$1.23M to -$1.11M, EBIT increased 10.33% from -$661.5 to -$593.2, and earnings per share increased from -$0.16 to -$0.1435.
MEDIROM Inc. (MRM) was upgraded to D from D- on 12/28/2022 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 10.33% from -$1.23M to -$1.11M, EBIT increased 10.33% from -$661.5 to -$593.2, and earnings per share increased from -$0.16 to -$0.1435.
D
Sell
11/22/2022Downgrade
MEDIROM Inc. (MRM) was downgraded to D- from D on 11/22/2022 due to a significant decline in the solvency index, growth index and total return index. Total revenue declined 3.16% from $14.91M to $14.44M, and EBIT declined 3.15% from $339.8 to $329.1.
MEDIROM Inc. (MRM) was downgraded to D- from D on 11/22/2022 due to a significant decline in the solvency index, growth index and total return index. Total revenue declined 3.16% from $14.91M to $14.44M, and EBIT declined 3.15% from $339.8 to $329.1.
D
Sell
5/16/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
MEDIROM Inc. (MRM) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and total return index.
E
Sell
5/13/2022Downgrade
MEDIROM Inc. (MRM) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
MEDIROM Inc. (MRM) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
5/4/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
MEDIROM Inc. (MRM) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell
5/1/2022Downgrade
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 05/01/2022.
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
MEDIROM Inc. (MRM) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 04/20/2022.
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E+ from D on 04/20/2022.
D
Sell
3/30/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from D- on 3/30/2022 due to an increase in the total return index and volatility index.
MEDIROM Inc. (MRM) was upgraded to D from D- on 3/30/2022 due to an increase in the total return index and volatility index.
D
Sell
3/15/2022Downgrade
MEDIROM Inc. (MRM) was downgraded to D- from D on 3/15/2022 due to a decline in the volatility index and valuation index.
MEDIROM Inc. (MRM) was downgraded to D- from D on 3/15/2022 due to a decline in the volatility index and valuation index.
D
Sell
2/25/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from D- on 2/25/2022 due to an increase in the volatility index and total return index.
MEDIROM Inc. (MRM) was upgraded to D from D- on 2/25/2022 due to an increase in the volatility index and total return index.
D
Sell
1/18/2022Downgrade
MEDIROM Inc. (MRM) was downgraded to D- from D on 1/18/2022 due to a decline in the volatility index and total return index.
MEDIROM Inc. (MRM) was downgraded to D- from D on 1/18/2022 due to a decline in the volatility index and total return index.
D
Sell
1/3/2022Upgraded
MEDIROM Inc. (MRM) was upgraded to D from D- on 1/3/2022 due to a substantial increase in the growth index and total return index. Operating cash flow increased 3.06% from -$1.64M to -$1.59M, and EBIT increased 3.06% from -$2.27M to -$2.2M.
MEDIROM Inc. (MRM) was upgraded to D from D- on 1/3/2022 due to a substantial increase in the growth index and total return index. Operating cash flow increased 3.06% from -$1.64M to -$1.59M, and EBIT increased 3.06% from -$2.27M to -$2.2M.
D
Sell
9/1/2021Upgraded
MEDIROM Inc. (MRM) was upgraded to D- from E on 9/1/2021 due to an increase in the volatility index and valuation index.
MEDIROM Inc. (MRM) was upgraded to D- from E on 9/1/2021 due to an increase in the volatility index and valuation index.
E
Sell
6/1/2021Upgraded
MEDIROM Healthcare Technologies Inc. (MRM) was upgraded to E from E- on 06/01/2021.
MEDIROM Healthcare Technologies Inc. (MRM) was upgraded to E from E- on 06/01/2021.
E
Sell
5/18/2021None
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E- from U on 05/18/2021.
MEDIROM Healthcare Technologies Inc. (MRM) was downgraded to E- from U on 05/18/2021.
NASDAQ
03/10/2025 3:59PM Eastern
Quotes delayed
